Powered by
Tags
Medical product

Overview

BIENCO, an Australia consortium of experts, is establishing BIENCO Vision Pty Ltd to drive the translation and global commercialisation of a series of Medtech ophthalmic products using bioengineered tissue to address various stages of corneal disease and injury. We will have a significant and direct impact on blindness in the world, replacing donor tissue with bioengineered tissue, transforming how treatment is delivered, and underpinning basic science in the field of tissue engineering.

We will address the global unmet demand for corneal tissue by substantially increasing access to transplantable corneal tissue. Currently, each donor cornea can only be used to treat a single patient. Our strategies will enable approximately 30 patients to receive tailored treatment from each donor cornea.

Delegates

NSW Organ and Tissue Donation Service 2023.
Danielle Fisher
CEO
BIENCO-Group-shot-November-2023-scaled-1.jpg